Variabel'nost' arterial'nogo davleniya -novaya mishen' dlya profilaktiki insul'ta
- Autores: Ostroumova O.D1, Guseva T.F1, Khvorostyanaya I.V1
-
Afiliações:
- Edição: Nº 14 (2012)
- Páginas: 39-44
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279831
- ID: 279831
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The article discusses the variability of blood pressure (BP) as a risk factor for stroke. The possibilities of the combination of amlodipine with ACE inhibitor for reduction of BP variability and stroke risk are considered. Own research data on the effectiveness impact of a fixed combination of amlodipine and lisinopril on the BP level and variability within a day are presented.
Texto integral
Bibliografia
- Смертность населения Российской Федерации, 1998 г. (статистические материалы). М., 2006. 36 с.
- Гусев Е.И., Скворцова В.И., Стаховская Л.В. Проблема инсульта в Российской Федерации: время активных совместных действий // Журнал неврол. и психиатрии 2007. № 8. С. 4-10.
- Диагностика и лечение артериальной гипертензии. Российские рекомендации, 4-я редакция // Системные гипертензии 2010. № 3. С. 5-26.
- Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010;375:895-905.
- Sever PS, Dahlof B, Poulter NR, et al. Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. J Hypertens 2001;6:1139-47.
- Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethi-azide as required, in Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentral randomized controlled trial. Lancet 2005;366:895-906.
- Fratolla A, Parati G, Guspidi C, et al. Prognostic value of 24-hour pressure variability. J Hypertens 1993;11:1133-37.
- Parati G, Ulian L, Santucciu C, et al. Blood pressure variability, cardiovascular risk and antihypertensive treatment. J Hypertens 1995;13(4):527-34.
- Рогоза А.Н., Никольский В.П., Ощепкова Е.В. и др. Суточное мониторирование артериального давления при гипертонии. (Методические вопросы) / Под ред. Г.Г. Арабидзе, О.Ю. Атькова. М., 2005.
- Verdecchia P, Angeli F, Gattobigio R, et al. Impact of Blood Pressure Variability on Cardiac and Cerebrovascular Complications in Hypertension. Am J Hypertens 2007;20: 154-61.
- Rothwell PM, Howard SC, Dolan E, et al. ASCOT-BPLA and MRC Trial Investigators. Effects of beta-blockers and calcium-channel blockers on within individual variability in blood pressure and risk of stroke. Lancet Neurology 2010;9:469-80.